Unraveling the mysteries of syndrome X. As the number of Americans with insulin resistance grows, pharmacists can help patients prevent the onset of type 2 diabetes and cardiovascular disease.
The prevalence of insulin resistance and type 2 diabetes is rapidly increasing, primarily because of rising rates of obesity and physical inactivity. Insulin resistance syndrome is a metabolic disorder that often leads to a cluster of serious clinical conditions, including type 2 diabetes and cardiovascular disease. Optimal management of diabetes requires not only tight glycemic control but also stringent management of cardiovascular risk factors. Because of their ready access to patients, pharmacists are well positioned to help detect and manage the many conditions associated with insulin resistance.
Campbell
R Keith
RK
Washington State University College of Pharmacy, Pullman, USA.
D002318:Cardiovascular Diseases / Q000517:prevention & control; D003157:Community Pharmacy Services; D003924:Diabetes Mellitus, Type 2 / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D007333:Insulin Resistance; D024821:Metabolic Syndrome / Q000150:complications / Q000517:prevention & control*; D010595:Pharmacists / Q000706:statistics & numerical data*; D024382:Professional Role; D012307:Risk Factors